Daniela S. Katz
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
CBFB mutations predict endocrine therapy benefit in estrogen receptor-positive breast cancer.
Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2026
The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management.
Journal: Cells
Published: December 01, 2025
BRAF V600E Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature Review.
Journal: Oncology research
Published: July 11, 2025
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort.
Journal: Breast cancer (Tokyo, Japan)
Published: August 12, 2024
Identifying cultural, demographic, personal health and cancer-related barriers to integrative oncology care: a retrospective case-cohort study.
Journal: Journal of cancer research and clinical oncology
Published: May 01, 2023
First Female Patient with a Rare CIC-FOXO4-Translocated Sarcoma: A Case Report.
Journal: Case reports in oncology
Published: March 29, 2023
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Journal: Cancer
Published: September 11, 2019
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy.
Journal: NPJ breast cancer
Published: May 25, 2019
More Than 50 Subtypes of Soft Tissue Sarcoma: Paving the Path for Histology-Driven Treatments.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: September 21, 2018
Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levels.
Journal: BMC cancer
Published: July 11, 2018
Intratumoral immune-biomarkers and mismatch repair status in leiyomyosarcoma -potential predictive markers for adjuvant treatment: a pilot study.
Journal: Oncotarget
Published: August 09, 2017
Last Updated: 09/26/2026